JPRN-UMIN000035970已完成2 期
The efficacy of combination of Olanzapine, Aprepitant, Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving autologous peripheral blood stem cell transplantation for multiple myeloma - The efficacy of Olanzapin for PBSCT
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Uncontrolled active infection. 2)Active gastrointestinal ulcer. 3)Serious psychiatric illness. 4)Patient who is judged to be medically unfit by physician.
研究者
相似试验
已完成
3 期
Treatment of vomiting in breast cancer patientsCTRI/2017/12/010864Mysore medical college ad research institute
已完成
3 期
Aprepitant and Olanzapine in the treatment of vomitingCTRI/2017/12/010869Mysore medical college ad research institute
招募中
3 期
Olanzapine versus Aprepitant in the triplet regimen for preventing highly emetogenic chemotherapy-induced nausea and vomiting: a double blind, non-inferiority, randomized phase 3 trialmalignant tumor(only solid tumor)JPRN-UMIN000034225Department of Surgery, Keio University School of Medicine130
尚未招募
不适用
To Compare the changes in Neurocognitive profile in patients suffering with schizophrenia on treatment with Aripiprazole and OlanzapineCTRI/2021/05/033511Government Medical College and Hospital
招募中
3 期
Comparison between Olanzapine- Aprepitant- Granisetron on nausea and vomitingIRCT20190217042735N1Zahedan University of Medical Sciences105